Aptevo Therapeutics Inc.·3

Jun 22, 11:44 AM ET

NIOWAVE, INC. 3

3 · Aptevo Therapeutics Inc. · Filed Jun 22, 2026

Insider Transaction Report

Form 3
Period: 2026-05-25
NIOWAVE, INC.
10% Owner
Holdings
  • Common Stock

    98,522
  • Warrant (right to buy)

    Exercise: $8.00From: 2026-05-25Exp: 2031-05-25Common Stock (53,201 underlying)
Signature
Jaime A Lerma|2026-06-22

Documents

1 file
  • 3
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT